Skip to Main Content

Precision medicine for patients with co-existent ovarian and endometrial cancer: the COMPARE trial

Charting the cellular spacial landscape in rare ovarian cancer

CHARM Early Detection Clinical Trial

Re-VOLVE trial: using genomics to make treatment decisions after a PARP inhibitor